Skip to main content

Advertisement

SpringerLink
Log in

Early diagnosis and discontinuation of the offending agent is critical in drug-induced lupus erythematosus

  • Drug Reactions and Interactions
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Chang C, Gershwin ME. Drug-induced lupus erythematosus: incidence, management and prevention. Drug Saf 2011; 34(5): 357–74

    Article  PubMed  CAS  Google Scholar 

  2. Noel B. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol 2007 Jan; 21(1): 17–24

    Article  PubMed  CAS  Google Scholar 

  3. Yokoyama T, Usui T, Kiyama K, et al. Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men. Mod Rheumatol 2010 Aug; 20(4): 405–9

    Article  PubMed  Google Scholar 

  4. Reich A, Bialynicki-Birula R, Szepietowski JC. Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine. Int J Dermatol 2006 Sep; 45(9): 1112–4

    Article  PubMed  Google Scholar 

  5. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus: a systematic review. Dermatology 2000; 200(3): 223–31

    Article  PubMed  CAS  Google Scholar 

  6. Dunphy J, Oliver M, Rands AL, et al. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 2000 Mar; 142(3): 461–7

    Article  PubMed  CAS  Google Scholar 

  7. El-Hallak M, Giani T, Yeniay BS, et al. Chronic minocycline-induced autoimmunity in children. J Pediatr 2008; 153(3): 314–9

    Article  PubMed  CAS  Google Scholar 

  8. De Rycke L, Baeten D, Kruithof E, et al. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis. Arthritis Rheum 2005 Jul; 52(7): 2192–201

    Article  PubMed  Google Scholar 

  9. Eriksson C, Engstrand S, Sundqvist KG, et al. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα. Ann Rheum Dis 2005 Mar; 64(3): 403–7

    Article  PubMed  CAS  Google Scholar 

  10. Vermeire S, Noman M, Van Assche G, et al. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn’s disease: a prospective cohort study. Gastroenterology 2003 Jul; 125(1): 32–9

    Article  PubMed  CAS  Google Scholar 

  11. Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor a agents. Semin Arthritis Rheum 2008 Jun; 37(6): 381–7

    Article  PubMed  CAS  Google Scholar 

  12. Niewold TB, Clark DN, Salloum R, et al. Interferon alpha in systemic lupus erythematosus. J Biomed Biotechnol 2010: 948364

  13. Gogas H, Ioannovich J, Dafni U, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Engl J Med 2006 Feb 16; 354(7): 709–18

    Article  PubMed  CAS  Google Scholar 

  14. Rönnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991 Aug 1; 115(3): 178–83

    PubMed  Google Scholar 

  15. Atkins MB, Mier JW, Parkinson DR, et al. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988 Jun 16; 318(24): 1557–63

    Article  PubMed  CAS  Google Scholar 

  16. Massarotti EM, Liu NY, Mier J, et al. Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy. Am J Med 1992 Jun; 92(6): 693–7

    Article  PubMed  CAS  Google Scholar 

  17. Borchers AT, Keen CL, Gershwin ME. Drug-induced lupus. Ann N Y Acad Sci 2007 Jun; 1108: 166–82

    Article  PubMed  CAS  Google Scholar 

  18. Lupus™ Foundation of America, Inc. Drug-induced lupus [online]. Available from URL: http://www.lupus.org [Accessed 2011 Jul 18]

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Early diagnosis and discontinuation of the offending agent is critical in drug-induced lupus erythematosus. Drugs Ther. Perspect 27, 19–22 (2011). https://doi.org/10.2165/11606130-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11606130-000000000-00000

Search

Navigation